ImmunityBio, Inc. IBRX

$IBRX added 25K shares at 7.32!!!

Let's break 7 !!!!

Burn the shorts!!!

$IBRX Hold longs, it's great to see the stock start accumulating instead of rocket high, so I can hold long without any worry. Patrick is a guy who don't cut the corner. IBRX would become a stable and growing stock. Don't play it short, keep it long. N803 would become the next generation immune cancer medicine. I hope MERK will coliberate with PSS, to accelerate this perfect combination (IL-15 + checkpoint inhibitor). That's going to be the true moonshot for human.

$IBRX Less risk after approval, will hold long until LUNG cancer become next indication. Revenue from Bladder cancer would be huge. The results of clinical trial for Lung CA are similar to the bladder cancer, which mean a NK and T cell booster + Checkpoint inhibitor (MERK's pembrolizuman) will definitely get the approval for Lung.

$IBRX partnership with MERK would be wonderful !!! N803 + PD1 inhibitor = perfect combination!!!

$IBRX short try to attack but in vain. Hold it and you get short squeeze to 6-8 per share tomorrow!!!

$IBRX I sold 20K shares (2/3 of my shares) at 5.0 before FDA approval to de-risk. Buying back 20K shares at 4.97 today as there's no risk anymore after approval.

$IBRX added 20K shares. Relatively cheaper and less risk after approval. Will hold until LUNG cancer become next indication.

$IBRX add another 20K shares.